1月5日 - ** 透析产品制造商罗克韦尔医疗RMTI.O股价盘前上涨7.7%至93美分
** 公司称已将与美国最大透析供应商之一的产品采购协议延长至 2026 年 12 月
** 根据修订后的协议，透析产品的价格将提高 - RMTI
** 公司开发并销售用于治疗终末期肾病的产品
** 产品用于透析中心、医院、护理机构和家庭 - Co
** 截至上次收盘，股价在过去 1 年中上涨了 ~4
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.